The effect of aging on the response of striatal preproenkephalin and preprotachykinin mRNA contents to chronic haloperidol treatment in rats: Measurement by solution-hybridization RNase protection assay

Neuroscience Letters

Volumn 246, Issue 1, 1998, Pages 33-36

  Lau, S M ^a   Tang, F ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Aging; Dopamine receptors; Haloperidol; Preproenkephalin mRNA; Preprotachykinin mRNA; Protection assay; Solution hybridization RNase; Striatum

Indexed keywords

HALOPERIDOL; MESSENGER RNA; PREPROENKEPHALIN; PREPROTACHYKININ;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENZYME ASSAY; GENE EXPRESSION REGULATION; HYBRIDIZATION; NEUROTRANSMISSION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT;

AGING; ANIMALS; CORPUS STRIATUM; ENKEPHALINS; HALOPERIDOL; MALE; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TACHYKININS;

EID: 0032540477     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00202-X     Document Type: Article

References (24)

1. Abood M.E., Eberwine J.H., Erdelyi E., Evans C.J. Regulation of both preproenkephalin mRNA and its derived opioids by haloperidol - a method for measurement of peptides and mRNA in the same tissue extract. Mol. Brain Res. 8:1990;243-248.
2. Bannon M.J., Lee J.M., Giraud P., Young A., Affolter H.U., Bonner T.I. Dopamine antagonist haloperidol decrease substance P, substance K and preprotachykinin mRNAs in rat striatonigral neurons. J. Biol. Chem. 261:1986;6640-6642.
3. Bernard V., Le Moine C., Bloch B. Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidal treatment: a quantitative in situ hybridization study. Neuroscience. 45:1991;117-126.
4. Carter M.S., Krause J.E. Structure, expression, and some regulatory mechanisms of the rat pre-protachykinin gene encoding substance P, neurokinin A, neuropeptide K and neuropeptide. J. Neurosci. 10:1990;2203-2214.
5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
6. Hanson G.R., Alphs L., Wolf W., Pradhan S., Lovenberg W. Response of striatonigral substance P systems to a dopamine receptor agonist and antagonist. Neuropharmacology. 20:1981;541-548.
7. Haverstick D.M., Rubenstein A., Bannon M.J. Striatal tachykinin gene expression regulated by interaction of D1 and D2 dopamine receptors. J. Pharmacol. Exp. Ther. 248:1989;858-862.
8. Hong J.S., Yang H.Y., Costa E. Substance P content of substantia nigra after chronic treatment with antischizophrenic drugs. Neuropharmacology. 17:1978;83-85.
9. Hong J.S., Yang H.Y.T., Gillin J.C., Di Giulio A.M., Fratta W., Costa E. Chronic treatment with haloperidol accelerates the biosynthesis of enkephalin in rat striatum. Brain Res. 160:1979;192-195.
10. Hyttel J. Age related decrease in the density of dopamine D1 and D2 receptors in corpus striatum of rats. Pharmacol. Toxicol. 61:1987;126-129.
11. Lau S.M., Tang F. The effect of haloperidol on met-enkephalin, beta-endorphin, cholecytokinin and substance P in the pituitary, the hypothalamus and the striatum of rats during aging. Prog. Neuro-Psychopharmacol. Biol. Psychiatr. 19:1995;1163-1175.
12. Li S.J., Sivam P., McGinty J.F., Huang Y.S., Hong J.S. Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway. J. Pharmacol. Exp. Ther. 243:1987;792-798.
13. Lindefors N. Amphetamine and haloperidol modulate preprotachykinin A mRNA expression in rat nucleus accumbens and caudate-putamen. Mol. Brain Res. 13:1992;151-154.
14. Nylander I., Terenius L. Chronic haloperidol and clozapine differentially affect dynorphin peptides and substance P in basal ganglia of the rat. Brain Res. 380:1986;34-41.
15. Ponzio F., Calderini G., Lomuscio G., Vantini G., Toffano G., Algeri S. Changes in monoamines and their metabolite levels in some brain regions of aged rats. Neurobiol. Aging. 3:1982;23-29.
16. Pradhan S.N. Central neurotransmitters and aging. Life Sci. 26:1980;1643-1656.
17. Reis D.J., Ross R.A., Tong H.J. Changes in the activity and amounts of enzymes synthesizing catecholamines and acetylcholine in brain, adrenal medulla and sympathetic ganglia of aged rat and mouse. Brain Res. 136:1977;465-474.
18. Ritter J.K., Schmidt C.J., Gibb J.W., Hanson G.R. Increases of substance P-like immunoreactivity within striatal-nigral structures after subacute methamphetamine treatment. J. Pharmacol. Exp. Ther. 229:1984;487-492.
19. Sabol S.L., Yoshikawa K., Hong J.S. Regulation of methionine-enkephalin precursor messenger RNA in rat striatum by haloperidol and lithium. Biochem. Biophys. Res. Commun. 113:1983;391-399.
20. Sivam S.P., Strunk C., Smith D.R., Hong J.S. Proenkephalin-A gene regulation in the rat striatum: influence of lithium and haloperidol. Mol. Pharmacol. 30:1986;186-191.
21. Tang F., Costa E., Schwarz J.P. Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks. Proc. Natl. Acad. Sci. USA. 80:1983;3841-3844.
22. Tang F., Lau S.M. Chronic haloperidol treatment decreases preproenkephalin mRNA in the anterior pituitary: a study by solution-hybridization-RNase protection assay. Neurosci. Lett. 221:1996;66-68.
23. Tang F., Man S.Y. Hypothyroidism and pituitary contents of immunoactive met-enkephalin and β-endorphin in male rats of different ages. Proc. Soc. Exp. Biol. Med. 188:1988;82-86.
24. Wang Z.P., Man S.Y., Tang F. Age related changes in the content of neuropeptides in the rat brain and pituitary. Neurobiol. Aging. 14:1993;529-534.